References

Acute renal failure in critically ill patients: a multinational, multicenter study

10.1001/jama.294.7.813 · 2005 · External reference

RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis

10.1186/cc4915 · 2006 · External reference

Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study

10.1186/cc3879 · 2005 · External reference

Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia

10.1097/00003246-200110000-00010 · 2001 · External reference

Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure

10.1093/ndt/11.2.293 · 1996 · External reference

Survival and quality of life of patients requiring acute renal replacement therapy

10.1007/s00134-005-2681-6 · 2005 · External reference

One-year mortality in critically ill patients by severity of kidney dysfunction: A population based assessment

10.1053/j.ajkd.2006.06.002 · 2006 · External reference

Recovery from acute kidney injury is an independent predictor of survival at 30 days only after out-of-hospital cardiac arrest who were treated by targeted temperature management

2021 · External reference

Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes

10.2215/cjn.03681106 · 2007 · External reference

Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup

10.1038/s41581-023-00683-3 · 2023 · External reference

The third international consensus definitions for sepsis and septic shock (Sepsis-3)

10.1001/jama.2016.0287 · 2016 · External reference

KDIGO clinical practice guidelines for acute kidney injury

10.1159/000339789 · 2012 · External reference

Red blood cell distribution width to albumin ratio is linked to all-cause mortality in critically ill patients with acute kidney injury: a retrospective cohort study

2024 · External reference

A large-scale multicenter retrospective study on nephrotoxicity associated with empiric broad-spectrum antibiotics in critically ill patients

10.1016/j.chest.2023.03.046 · 2023 · External reference

Continuous vs intermittent meropenem administration in critically ill patients with sepsis: the MERCY randomized clinical trial

10.1001/jama.2023.10598 · 2023 · External reference

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

10.1016/s1473-3099(14)70036-2 · 2014 · External reference

Antimicrobial pharmacodynamics

10.1038/nrmicro862 · 2004 · External reference

Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): a multicenter randomized double-blind trial

2021 · External reference

Augmented renal clearance

10.1002/phar.2231 · 2019 · External reference

Obesity: preventing and managing the global epidemic. Report of a WHO consultation

2000 · External reference

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study

10.1001/jama.1993.03510240069035 · 1993 · External reference

Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection

10.1371/journal.pone.0201667 · 2018 · External reference

Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis

10.1016/s1473-3099(17)30615-1 · 2018 · External reference

Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections

10.1016/j.ijantimicag.2014.01.027 · 2014 · External reference

Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam

10.1093/cid/cis857 · 2013 · External reference

Prolonged versus intermittent β-lactam antibiotics intravenous infusion strategy in sepsis or septic shock patients

10.1186/s40560-020-00490-z · 2020 · External reference

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021

10.1007/s00134-021-06506-y · 2021 · External reference

Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2026

10.1097/ccm.0000000000007089 · 2026 · External reference

Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis

10.1007/s00134-015-4188-0 · 2016 · External reference

10.1093/jac/dkv288

10.1093/jac/dkv288 · 2016 · External reference

Meropenem PK/PD variability and renal function: “we go together”

10.3390/pharmaceutics15092238 · 2023 · External reference

A multicenter randomized trial of continuous versus intermittent beta-Lactam infusion in severe sepsis

10.1164/rccm.201505-0857oc · 2015 · External reference

III Study Investigators. Continuous vs intermittent beta-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial

10.1001/jama.2024.9779 · 2024 · External reference

Prolonged vs intermittent infusions of β-lactam antibiotics in adults with sepsis or septic shock: a systematic review and meta-analysis

10.1001/jama.2024.9803 · 2024 · External reference

Duration of exposure to antipseudomonal beta-lactam antibiotics in the critically ill and development of new resistance

10.1002/phar.2201 · 2019 · External reference

Association between augmented renal clearance and clinical outcomes in patients receiving beta-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial

10.1016/j.ijantimicag.2016.12.022 · 2017 · External reference